Clinical trial data shows average weight loss of approximately 15 percent of total body weight over 68 weeks
In their clinical trials, Ozempic / Wegovy have been shown to reduce the risk of a recurrent major adverse cardiac event (heart attack / stroke) by 20% over 5 years
Knowing that GLP-1 drugs have proven effective at reducing inflammation and improving vascular health, Oregon Health & Science University researchers were interested in how the meds would affect AMD, which is classified as an inflammatory disease
How It Works Our Treatment Process From your first consultation to ongoing support, here's what to expect on your journey
Research has explored IGF1 LR3s possible in bone body function, where it appears to boost osteoblast activity and bone formation
Instead it works through a distinct set of mechanisms: NFB inhibition: KPV's primary action is blocking NFB, the master switch that drives inflammatory gene expression in immune and epithelial cells